News
APDN
0.1771
-5.29%
-0.0099
Applied DNA customer UHKT initiates Phase I clinical trial of UHKT-CAR123-01
TipRanks · 4d ago
US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak
Benzinga · 4d ago
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
Benzinga · 5d ago
APPLIED DNA SCIENCES INC. FORM 10-K FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2024
Press release · 5d ago
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 5d ago
*Applied DNA: James Hayward, Who Was President, Remains CEO and Chairman
Dow Jones · 5d ago
*Applied DNA Chief Operating Officer Judith Murrah to Become President
Dow Jones · 5d ago
*Applied DNA 4Q Rev $813,106 >APDN
Dow Jones · 5d ago
Applied DNA Sciences Inc reports results for the quarter ended September 30 - Earnings Summary
Reuters · 5d ago
*Applied DNA to Pursue Divestiture of CertainT Platform
Dow Jones · 5d ago
*Applied DNA 4Q Loss/Shr 32c >APDN
Dow Jones · 5d ago
*Applied DNA Sciences Announces Restructuring
Dow Jones · 5d ago
Applied DNA Sciences GAAP EPS of -$0.32 beats by $0.02, revenue of $0.81M misses by $0.09M
Seeking Alpha · 5d ago
Applied DNA Sciences Announces Leadership Changes and Restructuring
TipRanks · 5d ago
Applied DNA Reveals Immediate Promotion Of COO Judith Murrah To President; James Hayward Remains Chairman Of Board And CEO
Benzinga · 5d ago
Applied DNA Sciences Q4 2024 GAAP EPS $(0.32) Beats $(0.34) Estimate, Sales $813.11K Miss $899.00K Estimate
Benzinga · 5d ago
APPLIED DNA SCIENCES INC - TARGETING OF OPERATING EXPENSE REDUCTIONS OF 15% COMPARED TO FISCAL 2024
Reuters · 5d ago
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot
Barchart · 5d ago
Earnings Scheduled For December 17, 2024
Benzinga · 6d ago
More
Webull provides a variety of real-time APDN stock news. You can receive the latest news about Applied Dna Scie through multiple platforms. This information may help you make smarter investment decisions.
About APDN
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.